Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1176

Lacto-N-tetraose

Intended Use: Intended for use as an ingredient in milk- and soy-based, non-exempt infant formula for term infants at a maximum level of 0.8 g/L. Intended for use as an ingredient in non-milk-based and milk-based meal-replacement and protein drinks; sports, isotonic, and energy drinks; soft drinks; enhanced or fortified waters; meal-replacement bars; cereal and granola bars; unflavored pasteurized and sterilized milk; buttermilk; flavored milk; yogurt; meal replacement drinks for young children; nutritional drinks for pregnant women; fruit drinks and ades; formulas and other drinks intended for children >12 months of age; cereals and other foods for infants and young children; oral electrolyte solutions; and formula for enteral tube feeding at levels up to 2.0 g/100 g.
Basis: Scientific procedures
Notifier: FrieslandCampina Ingredients B.V.
Notifier Address: P.O. Box 1551
3800 BN Amersfoort
The Netherlands
GRAS Notice (releasable information): GRN 1176 with amendments (in PDF) (6.9 MB)
Date of closure: Sep 24, 2024
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (109 kB)
-
-